Zai Lab (ZLAB) Accounts Payables (2016 - 2026)
Zai Lab (ZLAB) posted Accounts Payables of $126.2 million for Q1 2026, down 10.9% sequentially from $141.6 million in Q4 2025, and up 22.47% YoY from $103.0 million in Q1 2025.
Zai Lab (ZLAB) Accounts Payables (2016 - 2026) Analysis & Trends
Zai Lab has reported Accounts Payables for 11 years, with the latest figure at $126.2 million in Q1 2026.
- Quarterly Accounts Payables rose 22.47% year-over-year to $126.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $126.2 million (up 22.47% YoY) and the FY2025 annual result came in at $141.6 million, up 40.34% from the prior year.
- Accounts Payables fell to $126.2 million in Q1 2026 per ZLAB's latest filing, from $141.6 million in the prior quarter.
- Over five years, Accounts Payables peaked at $141.6 million in Q4 2025 and troughed at $55.0 million in Q3 2023.
- A 5-year average of $98.8 million and a median of $100.9 million in 2024 frame the typical range for Accounts Payables.
- The widest YoY moves for Accounts Payables: up 137.02% in 2022, down 47.71% in 2022.
- Over 5 years, Accounts Payables stood at $66.0 million in 2022, then soared by 71.27% to $113.0 million in 2023, then slipped by 10.7% to $100.9 million in 2024, then soared by 40.34% to $141.6 million in 2025, then retreated by 10.9% to $126.2 million in 2026.
- According to Business Quant data, Accounts Payables over the past three periods registered $126.2 million, $141.6 million, and $99.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Zai Lab | 2.91 Bn | 2.20 Bn | 58.15 Mn | 136.69 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 136.69 Mn |
| Mar 31, 2026 | 126.17 Mn |
| Dec 31, 2025 | 141.61 Mn |
| Sep 30, 2025 | 99.71 Mn |
| Jun 30, 2025 | 107.36 Mn |
| Mar 31, 2025 | 103.02 Mn |
| Dec 31, 2024 | 100.91 Mn |
| Sep 30, 2024 | 120.65 Mn |
| Jun 30, 2024 | 127.34 Mn |
| Mar 31, 2024 | 88.12 Mn |
| Dec 31, 2023 | 112.99 Mn |
| Sep 30, 2023 | 55.02 Mn |
| Jun 30, 2023 | 67.03 Mn |
| Mar 31, 2023 | 66.36 Mn |
| Dec 31, 2022 | 65.97 Mn |
| Sep 30, 2022 | 90.11 Mn |
| Jun 30, 2022 | 108.44 Mn |
| Mar 31, 2022 | 98.16 Mn |
| Dec 31, 2021 | 126.16 Mn |
| Sep 30, 2021 | 51.41 Mn |